Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Share Prices: John Goltermann of Obermeyer Asset Management Talks Apple

Page 1 of 2

Apple Share Prices: Even when investors were salivating over Apple Inc. (NASDAQ:AAPL) during the spring of 2012, John Goltermann of Obermeyer Asset Management was telling people to be careful. It turns out that his assessment of the company was right.

Shares of Apple have fallen over 25% in the past six months, and there are many ways to trade the tech giant. Check out Insider Monkey’s market-beating strategy here.

Apple Inc (AAPL)The question remains: what does Goltermann think right now about buying Apple Inc. (NASDAQ:AAPL)?

During an interview with CNBC’s Gary Kaminsky, he says he is “still skeptical” of the stock. That being said, he doesn’t stop there. He has plenty of additional advice and insight for Wall Street.

Despite the fact that only a small portion of the interview touches on Apple Inc. (NASDAQ:AAPL), Goltermann shares some great insight as to where things stand right now and what the future may hold:

“My take on Apple is that a lot of the euphoria has come off the stock price lately. I think it is down about $80 since we spoke last time. We have always viewed Apple as kind of a complicated investment. It is more complicated than that it makes cool devices and its one of those where it has to continually be on the leading edge of innovation in order to sustain its stock price.”

Goltermann then went on to add his view on future product releases:

“That is very difficult to do (be on the leading edge of innovation) in our opinion. Over the near term, you know I would expect some more focus on results here. We are kind of in between product launches and its difficult to say how the market will react to new product announcements. But I think the focus is going to be more centered on the economics of the business and whether or not its able to continue its leading edge.”

If you don’t believe what Goltermann has to say, keep this tidbit in mind as published by CNBC:

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!